Alimentary Pharmacology & Therapeutics | Scinapse

Alimentary Pharmacology & Therapeutics

IF

8.17

Papers

10.7k

Papers 10,000

1 page of 1,000 pages (10k results)

Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives

Jul 6, 2022·Alimentary Pharmacology & Therapeutics

Treatment patterns of anti‐tumour necrosis factor‐alpha and prognosis of paediatric and adult‐onset inflammatory bowel disease in Korea: a nationwide population‐based study

Jul 6, 2022·Alimentary Pharmacology & Therapeutics

Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease

Jul 4, 2022·Alimentary Pharmacology & Therapeutics

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study

Jul 3, 2022·Alimentary Pharmacology & Therapeutics

Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.

Jul 1, 2022·Alimentary Pharmacology & Therapeutics

Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.

Jul 1, 2022·Alimentary Pharmacology & Therapeutics

Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply.

Jul 1, 2022·Alimentary Pharmacology & Therapeutics

Editorial: acute severe autoimmune hepatitis-a diagnostic and therapeutic dilemma.

Jul 1, 2022·Alimentary Pharmacology & Therapeutics

Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain.

Jul 1, 2022·Alimentary Pharmacology & Therapeutics

12345678910

Top fields of study

This website uses cookies.

We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.